ProQR Therapeutics - 53 Year Dividend History | PRQR
Historical dividend payout and yield for ProQR Therapeutics (PRQR) since 1971. The current TTM dividend payout for ProQR Therapeutics (PRQR) as of November 29, 2024 is $0.00. The current dividend yield for ProQR Therapeutics as of November 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.314B |
$0.007B |
|
ProQR Therapeutics B.V. is a biotech company. It is engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, with an initial focus on Cystic Fibrosis (CF). The Company's lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. ProQR Therapeutics B.V. is headquartered in Leiden, the Netherlands.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
